Skip to main content
Erschienen in: Neurological Sciences 10/2020

20.04.2020 | Original Article

Understanding patients’ and caregivers’ perspectives and educational needs in Parkinson’s disease: a multi-ethnic Asian study

verfasst von: Xing Yan Choo, Shen-Yang Lim, Karuthan Chinna, Yan Jing Tan, Voon Wei Yong, Jia Lun Lim, Kar Foo Lau, Jing Yi Chung, Jun Min Em, Hui Ting Tan, Jia Hwa Lim, Seng Beng Tan, Chong Tin Tan, Ai Huey Tan

Erschienen in: Neurological Sciences | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Little is known regarding the educational needs and perspectives of people living with Parkinson’s disease (PD), particularly in Asia.

Objective

To assess knowledge and perceptions regarding PD in a large multiethnic urban Asian cohort of patients and caregivers.

Methods

We conducted a survey at a university hospital neurology clinic, using a novel Knowledge and Perception of Parkinson’s Disease Questionnaire (KPPDQ).

Results

The KPPDQ had satisfactory psychometric properties among patients and caregivers. Five hundred subjects were recruited with a 97% response rate (211 patients, 273 caregivers). Non-motor symptoms such as urinary problems, visual hallucinations and pain were relatively poorly recognized. Many (≈ 50–80%) respondents incorrectly believed that all PD patients experience tremor, that PD is usually familial, and that there is a cure for PD. About one-half perceived PD to be caused by something the patient had done in the past, and that PD medications were likely to cause internal organ damage. Issues of stigma/shame were relevant to one-third of patients, and 70% of patients perceived themselves to be a burden to others. Two-thirds of participants felt that PD imposed a heavy financial toll. Participants were about equally divided as to whether they would consider treatment with deep brain stimulation, tube feeding or invasive ventilation. Over three-quarters of patients expressed a preference to die at home.

Conclusions

Important knowledge gaps, misperceptions and perspectives on PD were identified, highlighting the need for further efforts to raise awareness and provide accurate information regarding PD, and to address patient’s and caregivers’ needs and preferences.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat GBD 2016 Parkinson’s Disease Collaborators (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939–953 GBD 2016 Parkinson’s Disease Collaborators (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939–953
2.
Zurück zum Zitat Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601PubMed Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601PubMed
3.
Zurück zum Zitat Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435–450PubMed Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435–450PubMed
4.
Zurück zum Zitat Chaudhuri KR, Odin P (2010) The challenge of non-motor symptoms in Parkinson’s disease. Prog Brain Res 184:325–341PubMed Chaudhuri KR, Odin P (2010) The challenge of non-motor symptoms in Parkinson’s disease. Prog Brain Res 184:325–341PubMed
5.
Zurück zum Zitat Lim SY, Tan AH, Fox SH, Evans AH, Low SC (2017) Integrating patient concerns into Parkinson’s disease management. Curr Neurol Neurosci Rep 17:3PubMed Lim SY, Tan AH, Fox SH, Evans AH, Low SC (2017) Integrating patient concerns into Parkinson’s disease management. Curr Neurol Neurosci Rep 17:3PubMed
6.
Zurück zum Zitat Prakash KM, Nadkarni NV, Lye WK, Yong MH, Tan EK (2016) The impact of non-motor symptoms on the quality of life of Parkinson’s disease patients: a longitudinal study. Eur J Neurol 23:854–860PubMed Prakash KM, Nadkarni NV, Lye WK, Yong MH, Tan EK (2016) The impact of non-motor symptoms on the quality of life of Parkinson’s disease patients: a longitudinal study. Eur J Neurol 23:854–860PubMed
7.
Zurück zum Zitat Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Park Dis 8(s1):S3–S8 Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Park Dis 8(s1):S3–S8
8.
Zurück zum Zitat Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL et al (2019) Parkinson’s disease in the Western Pacific region. Lancet Neurol 18:865–879PubMed Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL et al (2019) Parkinson’s disease in the Western Pacific region. Lancet Neurol 18:865–879PubMed
9.
Zurück zum Zitat Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K (2011) Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 155:97–107PubMed Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K (2011) Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 155:97–107PubMed
10.
Zurück zum Zitat Tan AH, Tan CT, Marras C, Loh KW, Wye Ho NW, Lim QH, Tan PW, Lim CC, Cheong YW, Kong ST, Schee JP, Tan KH, Soo SK, Vanderschaaf C, Lai Heong Lew S, Mahamad UA, Goh KJ, Yong HS, Lim SY (2015) Knowledge of Parkinson’s disease in a multiethnic urban Asian setting. J Park Dis 5:865–879 Tan AH, Tan CT, Marras C, Loh KW, Wye Ho NW, Lim QH, Tan PW, Lim CC, Cheong YW, Kong ST, Schee JP, Tan KH, Soo SK, Vanderschaaf C, Lai Heong Lew S, Mahamad UA, Goh KJ, Yong HS, Lim SY (2015) Knowledge of Parkinson’s disease in a multiethnic urban Asian setting. J Park Dis 5:865–879
11.
Zurück zum Zitat Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA, LEAP Study Group (2019) Randomized delayed-start trial of levodopa in Parkinson’s disease. N Engl J Med 380:315–324PubMed Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA, LEAP Study Group (2019) Randomized delayed-start trial of levodopa in Parkinson’s disease. N Engl J Med 380:315–324PubMed
12.
Zurück zum Zitat Pagan FL (2012) Improving outcomes through early diagnosis of Parkinson’s disease. Am J Manag Care 18(7 Suppl):S176–S182PubMed Pagan FL (2012) Improving outcomes through early diagnosis of Parkinson’s disease. Am J Manag Care 18(7 Suppl):S176–S182PubMed
13.
Zurück zum Zitat van der Eijk M, Nijhuis FA, Faber MJ, Bloem BR (2013) Moving from physician-centered care towards patient-centered care for Parkinson’s disease patients. Parkinsonism Relat Disord 19:923–927PubMed van der Eijk M, Nijhuis FA, Faber MJ, Bloem BR (2013) Moving from physician-centered care towards patient-centered care for Parkinson’s disease patients. Parkinsonism Relat Disord 19:923–927PubMed
14.
Zurück zum Zitat Purks JL, Wilhelm EE, Shoulson I, Creveling J, Dorsey ER, Irony T, LoCastro T, Pagan F, Ravina B, Simuni T, Sterling M, Tariot P, Anderson KE (2017) Inaugural conference on incorporating patient-reported outcomes and patient preference information into clinical research, clinical care, and risk-benefit assessments for neurodegenerative diseases. Patient 10:541–544PubMedPubMedCentral Purks JL, Wilhelm EE, Shoulson I, Creveling J, Dorsey ER, Irony T, LoCastro T, Pagan F, Ravina B, Simuni T, Sterling M, Tariot P, Anderson KE (2017) Inaugural conference on incorporating patient-reported outcomes and patient preference information into clinical research, clinical care, and risk-benefit assessments for neurodegenerative diseases. Patient 10:541–544PubMedPubMedCentral
15.
Zurück zum Zitat Buetow SA, Martínez-Martín P, Hirsch MA, Okun MS (2016) Beyond patient-centered care: person-centered care for Parkinson’s disease. NPJ Parkinsons Dis 2:16019PubMedPubMedCentral Buetow SA, Martínez-Martín P, Hirsch MA, Okun MS (2016) Beyond patient-centered care: person-centered care for Parkinson’s disease. NPJ Parkinsons Dis 2:16019PubMedPubMedCentral
16.
Zurück zum Zitat Mosley PE, Moodie R, Dissanayaka N (2017) Caregiver burden in Parkinson disease: a critical review of recent literature. J Geriatr Psychiatry Neurol 30:235–252PubMed Mosley PE, Moodie R, Dissanayaka N (2017) Caregiver burden in Parkinson disease: a critical review of recent literature. J Geriatr Psychiatry Neurol 30:235–252PubMed
17.
Zurück zum Zitat Hiseman JP, Fackrell R (2017) Caregiver burden and the nonmotor symptoms of Parkinson’s disease. Int Rev Neurobiol 133:479–497PubMed Hiseman JP, Fackrell R (2017) Caregiver burden and the nonmotor symptoms of Parkinson’s disease. Int Rev Neurobiol 133:479–497PubMed
18.
Zurück zum Zitat van Rumund A, Weerkamp N, Tissingh G, Zuidema SU, Koopmans RT, Munneke M, Poels PJ, Bloem BR (2014) Perspectives on Parkinson disease care in Dutch nursing homes. J Am Med Dir Assoc 15:732–737PubMed van Rumund A, Weerkamp N, Tissingh G, Zuidema SU, Koopmans RT, Munneke M, Poels PJ, Bloem BR (2014) Perspectives on Parkinson disease care in Dutch nursing homes. J Am Med Dir Assoc 15:732–737PubMed
19.
Zurück zum Zitat Bhidayasiri R, Panyakaew P, Trenkwalder C, Jeon B, Hattori N, Jagota P, Wu YR, Moro E, Lim SY, Shang H, Rosales R, Lee JY, Thit WM, Tan EK, Lim TT, Tran NT, Binh NT, Phoumindr A, Boonmongkol T, Phokaewvarangkul O, Thongchuam Y, Vorachit S, Plengsri R, Chokpatcharavate M, Fernandez HH (2020) Delivering patient-centered care in Parkinson’s disease: challenges and consensus from an international panel. Parkinsonism Relat Disord 72:82–87PubMed Bhidayasiri R, Panyakaew P, Trenkwalder C, Jeon B, Hattori N, Jagota P, Wu YR, Moro E, Lim SY, Shang H, Rosales R, Lee JY, Thit WM, Tan EK, Lim TT, Tran NT, Binh NT, Phoumindr A, Boonmongkol T, Phokaewvarangkul O, Thongchuam Y, Vorachit S, Plengsri R, Chokpatcharavate M, Fernandez HH (2020) Delivering patient-centered care in Parkinson’s disease: challenges and consensus from an international panel. Parkinsonism Relat Disord 72:82–87PubMed
20.
Zurück zum Zitat Malek N, Grosset DG (2015) Medication adherence in patients with Parkinson’s disease. CNS Drugs 29:47–53PubMed Malek N, Grosset DG (2015) Medication adherence in patients with Parkinson’s disease. CNS Drugs 29:47–53PubMed
21.
Zurück zum Zitat Jitkritsadakul O, Boonrod N, Bhidayasiri R (2017) Knowledge, attitudes and perceptions of Parkinson’s disease: a cross-sectional survey of Asian patients. J Neurol Sci 374:69–74PubMed Jitkritsadakul O, Boonrod N, Bhidayasiri R (2017) Knowledge, attitudes and perceptions of Parkinson’s disease: a cross-sectional survey of Asian patients. J Neurol Sci 374:69–74PubMed
22.
Zurück zum Zitat Tripathi RK, Kapse SV, Potey AV (2017) Prescription pattern and awareness of disease and treatment in patients of Parkinson’s disease. Neurodegener Dis Manag 7:299–306PubMed Tripathi RK, Kapse SV, Potey AV (2017) Prescription pattern and awareness of disease and treatment in patients of Parkinson’s disease. Neurodegener Dis Manag 7:299–306PubMed
23.
Zurück zum Zitat Moore S, Knowles S (2006) Beliefs and knowledge about Parkinson’s disease. E-Journal Appl Psychol Clin Soc Issues 2:15–21 Moore S, Knowles S (2006) Beliefs and knowledge about Parkinson’s disease. E-Journal Appl Psychol Clin Soc Issues 2:15–21
25.
Zurück zum Zitat Yadav R, Shukla G, Goyal V, Singh S, Behari M (2012) Knowledge of Parkinson’s disease among patients and caregivers attending movement disorder clinic at a tertiary care centre in North India. Ann Indian Acad Neurol 15(4):294–296PubMedPubMedCentral Yadav R, Shukla G, Goyal V, Singh S, Behari M (2012) Knowledge of Parkinson’s disease among patients and caregivers attending movement disorder clinic at a tertiary care centre in North India. Ann Indian Acad Neurol 15(4):294–296PubMedPubMedCentral
26.
Zurück zum Zitat Boersma I, Jones J, Carter J, Bekelman D, Miyasaki J, Kutner J, Kluger B (2016) Parkinson disease patients’ perspectives on palliative care needs. What are they telling us? Neurol Clin Pract 6:209–219PubMedPubMedCentral Boersma I, Jones J, Carter J, Bekelman D, Miyasaki J, Kutner J, Kluger B (2016) Parkinson disease patients’ perspectives on palliative care needs. What are they telling us? Neurol Clin Pract 6:209–219PubMedPubMedCentral
27.
Zurück zum Zitat Wiblin L, Durcan R, Lee M, Brittain K (2017) The importance of connection to others in QoL in MSA and PSP. Parkinsons Dis 2017:5283259PubMedPubMedCentral Wiblin L, Durcan R, Lee M, Brittain K (2017) The importance of connection to others in QoL in MSA and PSP. Parkinsons Dis 2017:5283259PubMedPubMedCentral
28.
Zurück zum Zitat Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet. 373(9680):2055–2066PubMed Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet. 373(9680):2055–2066PubMed
29.
Zurück zum Zitat Sim J, Wright CC (2005) The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 85:257–268PubMed Sim J, Wright CC (2005) The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 85:257–268PubMed
31.
Zurück zum Zitat Lim SY, Tan AH (2018) Historical perspective: the pros and cons of conventional outcome measures in Parkinson’s disease. Parkinsonism Relat Disord 46(Suppl 1):S47–S52PubMed Lim SY, Tan AH (2018) Historical perspective: the pros and cons of conventional outcome measures in Parkinson’s disease. Parkinsonism Relat Disord 46(Suppl 1):S47–S52PubMed
32.
Zurück zum Zitat Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P (2010) Parkinson’s disease symptoms: the patient’s perspective. Mov Disord 25:1646–1651PubMed Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P (2010) Parkinson’s disease symptoms: the patient’s perspective. Mov Disord 25:1646–1651PubMed
33.
Zurück zum Zitat Silverdale MA, Kobylecki C, Kass-Iliyya L, Martinez-Martin P, Lawton M, Cotterill S, Chaudhuri KR, Morris H, Baig F, Williams N, Hubbard L, Hu MT, Grosset DG, UK Parkinson's Pain Study Collaboration (2018) A detailed clinical study of pain in 1957 participants with early/moderate Parkinson’s disease. Parkinsonism Relat Disord 56:27–32PubMedPubMedCentral Silverdale MA, Kobylecki C, Kass-Iliyya L, Martinez-Martin P, Lawton M, Cotterill S, Chaudhuri KR, Morris H, Baig F, Williams N, Hubbard L, Hu MT, Grosset DG, UK Parkinson's Pain Study Collaboration (2018) A detailed clinical study of pain in 1957 participants with early/moderate Parkinson’s disease. Parkinsonism Relat Disord 56:27–32PubMedPubMedCentral
34.
Zurück zum Zitat Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P (2010) The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:704–709PubMed Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P (2010) The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:704–709PubMed
35.
Zurück zum Zitat Lohmann K, Klein C (2008) Genetics of Parkinson disease. Continuum Lifelong Learning Neurol 14:90–113 Lohmann K, Klein C (2008) Genetics of Parkinson disease. Continuum Lifelong Learning Neurol 14:90–113
36.
Zurück zum Zitat Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15:1257–1272PubMed Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15:1257–1272PubMed
37.
Zurück zum Zitat Menza M (2000) The personality associated with Parkinson’s disease. Curr Psychiatry Rep 2:421–426PubMed Menza M (2000) The personality associated with Parkinson’s disease. Curr Psychiatry Rep 2:421–426PubMed
39.
Zurück zum Zitat Angulo J, Fleury V, Péron JA, Penzenstadler L, Zullino D, Krack P (2019) Shame in Parkinson’s disease: a review. J Park Dis 9:489–499 Angulo J, Fleury V, Péron JA, Penzenstadler L, Zullino D, Krack P (2019) Shame in Parkinson’s disease: a review. J Park Dis 9:489–499
40.
Zurück zum Zitat Maffoni M, Giardini A, Pierobon A, Ferrazzoli D, Frazzitta G (2017) Stigma experienced by Parkinson’s disease patients: a descriptive review of qualitative studies. Parkinsons Dis 2017:7203259PubMedPubMedCentral Maffoni M, Giardini A, Pierobon A, Ferrazzoli D, Frazzitta G (2017) Stigma experienced by Parkinson’s disease patients: a descriptive review of qualitative studies. Parkinsons Dis 2017:7203259PubMedPubMedCentral
41.
Zurück zum Zitat Heusinkveld LE, Hacker ML, Turchan M, Davis TL, Charles D (2018) Impact of tremor on patients with early stage Parkinson’s disease. Front Neurol 9:628PubMedPubMedCentral Heusinkveld LE, Hacker ML, Turchan M, Davis TL, Charles D (2018) Impact of tremor on patients with early stage Parkinson’s disease. Front Neurol 9:628PubMedPubMedCentral
42.
Zurück zum Zitat Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D (2010) Use of drugs with anticholinergic effect and impact on cognition in Parkinson’s disease: a cohort study. J Neurol Neurosurg Psychiatry 81:160–165PubMed Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D (2010) Use of drugs with anticholinergic effect and impact on cognition in Parkinson’s disease: a cohort study. J Neurol Neurosurg Psychiatry 81:160–165PubMed
43.
Zurück zum Zitat Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N (2008) Factors affecting health-related quality of life amongst Asian patients with Parkinson’s disease. Eur J Neurol 15:737–742PubMed Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N (2008) Factors affecting health-related quality of life amongst Asian patients with Parkinson’s disease. Eur J Neurol 15:737–742PubMed
44.
Zurück zum Zitat Kim R, Kim HJ, Jeon B (2018) The good, the bad, and the ugly of medical information on the internet. Mov Disord 33:754–757PubMed Kim R, Kim HJ, Jeon B (2018) The good, the bad, and the ugly of medical information on the internet. Mov Disord 33:754–757PubMed
45.
Zurück zum Zitat Connolly R, O'Brien T, Flaherty G (2014) Stem cell tourism: a web-based analysis of clinical services available to international travellers. Travel Med Infect Dis 12:695–701PubMed Connolly R, O'Brien T, Flaherty G (2014) Stem cell tourism: a web-based analysis of clinical services available to international travellers. Travel Med Infect Dis 12:695–701PubMed
46.
Zurück zum Zitat Gharaibeh B, Anderson JE, Deasy BM (2016) Combating the threat of stem cell tourism through patient education and government regulation. Innov Entrep Health 3:15–24 Gharaibeh B, Anderson JE, Deasy BM (2016) Combating the threat of stem cell tourism through patient education and government regulation. Innov Entrep Health 3:15–24
47.
Zurück zum Zitat Cyranoski D (2019) The potent effects of Japan's stem-cell policies. Nature 573:482–485PubMed Cyranoski D (2019) The potent effects of Japan's stem-cell policies. Nature 573:482–485PubMed
48.
Zurück zum Zitat Bega D, Gonzalez-Latapi P, Zadikoff C, Simuni T (2014) A review of the clinical evidence for complementary and alternative therapies in Parkinson’s disease. Curr Treat Options Neurol 16:314PubMed Bega D, Gonzalez-Latapi P, Zadikoff C, Simuni T (2014) A review of the clinical evidence for complementary and alternative therapies in Parkinson’s disease. Curr Treat Options Neurol 16:314PubMed
49.
Zurück zum Zitat Tan LC, Lau PN, Jamora RD, Chan ES (2006) Use of complementary therapies in patients with Parkinson’s disease in Singapore. Mov Disord 21:86–89PubMed Tan LC, Lau PN, Jamora RD, Chan ES (2006) Use of complementary therapies in patients with Parkinson’s disease in Singapore. Mov Disord 21:86–89PubMed
50.
Zurück zum Zitat Schrag A, Khan K, Hotham S, Merritt R, Rascol O, Graham L (2018) Experience of care for Parkinson’s disease in European countries: a survey by the European Parkinson’s Disease Association. Eur J Neurol 25:1410–e120PubMed Schrag A, Khan K, Hotham S, Merritt R, Rascol O, Graham L (2018) Experience of care for Parkinson’s disease in European countries: a survey by the European Parkinson’s Disease Association. Eur J Neurol 25:1410–e120PubMed
51.
Zurück zum Zitat Lewitt PA (2008) Levodopa for the treatment of Parkinson’s disease. N Engl J Med 359:2468–2476PubMed Lewitt PA (2008) Levodopa for the treatment of Parkinson’s disease. N Engl J Med 359:2468–2476PubMed
52.
Zurück zum Zitat Fahn S (2006) A new look at levodopa based on the ELLDOPA study. J Neural Transm Suppl 70:419–426 Fahn S (2006) A new look at levodopa based on the ELLDOPA study. J Neural Transm Suppl 70:419–426
53.
Zurück zum Zitat Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C, Movement Disorder Society Evidence-Based Medicine Committee (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord 33:1248–1266PubMed Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C, Movement Disorder Society Evidence-Based Medicine Committee (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord 33:1248–1266PubMed
54.
Zurück zum Zitat Espay AJ, Lang AE (2017) Common myths in the use of levodopa in Parkinson disease: when clinical trials misinform clinical practice. JAMA Neurol 74:633–634PubMed Espay AJ, Lang AE (2017) Common myths in the use of levodopa in Parkinson disease: when clinical trials misinform clinical practice. JAMA Neurol 74:633–634PubMed
55.
Zurück zum Zitat Boersma I, Jones J, Coughlan C, Carter J, Bekelman D, Miyasaki J et al (2017) Palliative care and Parkinson’s disease: caregiver perspectives. J Palliat Med 20:930–938PubMedPubMedCentral Boersma I, Jones J, Coughlan C, Carter J, Bekelman D, Miyasaki J et al (2017) Palliative care and Parkinson’s disease: caregiver perspectives. J Palliat Med 20:930–938PubMedPubMedCentral
56.
Zurück zum Zitat Baik JS, Kim JS, Koh SB, Cho JW, Lee PH, Ma HI, Kim YJ, Ahn TB, Kim SJ, Kim YD, Choi SM, Lee HW, Kim HT (2017) Patients and their caregivers’ burdens for Parkinson’s disease in Korea. J Mov Disord 10:109–115PubMedPubMedCentral Baik JS, Kim JS, Koh SB, Cho JW, Lee PH, Ma HI, Kim YJ, Ahn TB, Kim SJ, Kim YD, Choi SM, Lee HW, Kim HT (2017) Patients and their caregivers’ burdens for Parkinson’s disease in Korea. J Mov Disord 10:109–115PubMedPubMedCentral
57.
Zurück zum Zitat Castrioto A, Lhommée E, Moro E, Krack P (2014) Mood and behavioural effects of subthalamic stimulation in Parkinson’s disease. Lancet Neurol 13:287–305PubMed Castrioto A, Lhommée E, Moro E, Krack P (2014) Mood and behavioural effects of subthalamic stimulation in Parkinson’s disease. Lancet Neurol 13:287–305PubMed
58.
Zurück zum Zitat Bryant MS, Rintala DH, Graham JE, Hou JG, Protas EJ (2014) Determinants of use of a walking device in persons with Parkinson’s disease. Arch Phys Med Rehabil 95:1940–1945PubMedPubMedCentral Bryant MS, Rintala DH, Graham JE, Hou JG, Protas EJ (2014) Determinants of use of a walking device in persons with Parkinson’s disease. Arch Phys Med Rehabil 95:1940–1945PubMedPubMedCentral
59.
Zurück zum Zitat Hammarlund CS, Andersson K, Andersson M, Nilsson MH, Hagell P (2014) The significance of walking from the perspective of people with Parkinson’s disease. J Park Dis 4:657–663 Hammarlund CS, Andersson K, Andersson M, Nilsson MH, Hagell P (2014) The significance of walking from the perspective of people with Parkinson’s disease. J Park Dis 4:657–663
60.
Zurück zum Zitat Kegelmeyer DA, Parthasarathy S, Kostyk SK, White SE, Kloos AD (2013) Assistive devices alter gait patterns in Parkinson disease: advantages of the four-wheeled walker. Gait Posture 38:20–24PubMed Kegelmeyer DA, Parthasarathy S, Kostyk SK, White SE, Kloos AD (2013) Assistive devices alter gait patterns in Parkinson disease: advantages of the four-wheeled walker. Gait Posture 38:20–24PubMed
61.
Zurück zum Zitat Liao YC, Wu YR, Tsao LI, Lin HR (2013) The experiences of Taiwanese older individuals at different stages of Parkinson disease. J Neurosci Nurs 45:370–377PubMed Liao YC, Wu YR, Tsao LI, Lin HR (2013) The experiences of Taiwanese older individuals at different stages of Parkinson disease. J Neurosci Nurs 45:370–377PubMed
62.
Zurück zum Zitat Tan MMJ, Lim EC, Nadkarni NV, Lye WK, Tan EK, Prakash KM (2019) The characteristics of patients associated with high caregiver burden in Parkinson’s disease in Singapore. Front Neurol 10:561PubMedPubMedCentral Tan MMJ, Lim EC, Nadkarni NV, Lye WK, Tan EK, Prakash KM (2019) The characteristics of patients associated with high caregiver burden in Parkinson’s disease in Singapore. Front Neurol 10:561PubMedPubMedCentral
63.
Zurück zum Zitat Kwak J, Wallendal MS, Fritsch T, Leo G, Hyde T (2014) Advance care planning and proxy decision making for patients with advanced Parkinson disease. South Med J 107:178–185PubMed Kwak J, Wallendal MS, Fritsch T, Leo G, Hyde T (2014) Advance care planning and proxy decision making for patients with advanced Parkinson disease. South Med J 107:178–185PubMed
64.
Zurück zum Zitat Stavroulakis T, McDermott CJ (2016) Enteral feeding in neurological disorders. Pract Neurol 16:352–361PubMed Stavroulakis T, McDermott CJ (2016) Enteral feeding in neurological disorders. Pract Neurol 16:352–361PubMed
65.
Zurück zum Zitat Marois C, Amador MDM, Payan C, Lacomblez L, Bonnet AM, Degos B, Corvol JC, Vidailhet M, le Forestier N, Mesnage V, Grabli D (2017) Outcome of gastrostomy in parkinsonism: a retrospective study. Parkinsonism Relat Disord 43:110–113PubMed Marois C, Amador MDM, Payan C, Lacomblez L, Bonnet AM, Degos B, Corvol JC, Vidailhet M, le Forestier N, Mesnage V, Grabli D (2017) Outcome of gastrostomy in parkinsonism: a retrospective study. Parkinsonism Relat Disord 43:110–113PubMed
66.
Zurück zum Zitat Moens K, Houttekier D, Van den Block L et al (2015) Place of death of people living with Parkinson’s disease: a population-level study in 11 countries. BMC Palliat Care 14:28PubMedPubMedCentral Moens K, Houttekier D, Van den Block L et al (2015) Place of death of people living with Parkinson’s disease: a population-level study in 11 countries. BMC Palliat Care 14:28PubMedPubMedCentral
67.
Zurück zum Zitat Snell K, Pennington S, Lee M, Walker R (2009) The place of death in Parkinson’s disease. Age Ageing 38:617–619PubMed Snell K, Pennington S, Lee M, Walker R (2009) The place of death in Parkinson’s disease. Age Ageing 38:617–619PubMed
68.
Zurück zum Zitat Borasio GD (2013) The role of palliative care in patients with neurological diseases. Nat Rev Neurol 9:292–295PubMed Borasio GD (2013) The role of palliative care in patients with neurological diseases. Nat Rev Neurol 9:292–295PubMed
69.
Zurück zum Zitat Shaw ST, Vivekananda-Schmidt P (2017) Challenges to ethically managing Parkinson disease: an interview study of patient perspectives. J Patient Exp 4:191–196PubMedPubMedCentral Shaw ST, Vivekananda-Schmidt P (2017) Challenges to ethically managing Parkinson disease: an interview study of patient perspectives. J Patient Exp 4:191–196PubMedPubMedCentral
70.
Zurück zum Zitat Odin P, Chaudhuri KR, Slevin JT, Volkmann J, Dietrichs E, Martinez-Martin P et al (2015) Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson’s disease: consensus from an international survey and discussion program. Parkinsonism Relat Disord 21:1133–1144PubMed Odin P, Chaudhuri KR, Slevin JT, Volkmann J, Dietrichs E, Martinez-Martin P et al (2015) Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson’s disease: consensus from an international survey and discussion program. Parkinsonism Relat Disord 21:1133–1144PubMed
71.
Zurück zum Zitat Lökk J (2011) Lack of information and access to advanced treatment for Parkinson’s disease patients. J Multidiscip Healthc 4:433–439PubMedPubMedCentral Lökk J (2011) Lack of information and access to advanced treatment for Parkinson’s disease patients. J Multidiscip Healthc 4:433–439PubMedPubMedCentral
72.
Zurück zum Zitat Li J, Chen D, Song W, Chen K, Cao B, Huang R, Yang R, Shang H (2014) Survey on general knowledge on Parkinson’s disease in patients with Parkinson’s disease and current clinical practice for Parkinson’s disease among general neurologists from Southwest China. Clin Neurol Neurosurg 118:16–20PubMed Li J, Chen D, Song W, Chen K, Cao B, Huang R, Yang R, Shang H (2014) Survey on general knowledge on Parkinson’s disease in patients with Parkinson’s disease and current clinical practice for Parkinson’s disease among general neurologists from Southwest China. Clin Neurol Neurosurg 118:16–20PubMed
73.
Zurück zum Zitat Zizzo N, Bell E, Lafontaine AL, Racine E (2017) Examining chronic care patient preferences for involvement in health-care decision making: the case of Parkinson’s disease patients in a patient-centred clinic. Health Expect 20:655–664PubMed Zizzo N, Bell E, Lafontaine AL, Racine E (2017) Examining chronic care patient preferences for involvement in health-care decision making: the case of Parkinson’s disease patients in a patient-centred clinic. Health Expect 20:655–664PubMed
74.
Zurück zum Zitat Nijhuis FAP, van den Heuvel L, Bloem BR, Post B, Meinders MJ (2019) The patient's perspective on shared decision-making in advanced Parkinson’s disease: a cross-sectional survey study. Front Neurol 10:896PubMedPubMedCentral Nijhuis FAP, van den Heuvel L, Bloem BR, Post B, Meinders MJ (2019) The patient's perspective on shared decision-making in advanced Parkinson’s disease: a cross-sectional survey study. Front Neurol 10:896PubMedPubMedCentral
75.
Zurück zum Zitat Dorsey ER, Voss TS, Shprecher DR, Deuel LM, Beck CA, Gardiner IF, Coles MA, Burns RS, Marshall FJ, Biglan KM (2010) A U.S. survey of patients with Parkinson’s disease: satisfaction with medical care and support groups. Mov Disord 25:2128–2135PubMed Dorsey ER, Voss TS, Shprecher DR, Deuel LM, Beck CA, Gardiner IF, Coles MA, Burns RS, Marshall FJ, Biglan KM (2010) A U.S. survey of patients with Parkinson’s disease: satisfaction with medical care and support groups. Mov Disord 25:2128–2135PubMed
76.
Zurück zum Zitat Cohen P (1982) To be or not to be: control and balancing of type I and type II errors. Eval Program Plann 5(3):247–253 Cohen P (1982) To be or not to be: control and balancing of type I and type II errors. Eval Program Plann 5(3):247–253
Metadaten
Titel
Understanding patients’ and caregivers’ perspectives and educational needs in Parkinson’s disease: a multi-ethnic Asian study
verfasst von
Xing Yan Choo
Shen-Yang Lim
Karuthan Chinna
Yan Jing Tan
Voon Wei Yong
Jia Lun Lim
Kar Foo Lau
Jing Yi Chung
Jun Min Em
Hui Ting Tan
Jia Hwa Lim
Seng Beng Tan
Chong Tin Tan
Ai Huey Tan
Publikationsdatum
20.04.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 10/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04396-4

Weitere Artikel der Ausgabe 10/2020

Neurological Sciences 10/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.